Compounds > haloperidol decanoate

Page last updated: 2024-08-23

haloperidol decanoate and Neuroleptic Malignant Syndrome

haloperidol decanoate has been researched along with Neuroleptic Malignant Syndrome in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (28.57)	18.7374
1990's	3 (42.86)	18.2507
2000's	1 (14.29)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Apramian, A; Kajani, R; Liu, A; Ubhayakar, N; Vega, A; Xu, P	1
Becker, T; Kopf, A; Köster, J; Krömker, H; Schulz, A	1
Benati, F; Cesario, V; Lazzarin, M	1
McHugh, TP	1
Christodoulou, GN; Kontaxakis, VP; Vaidakis, NM; Valergaki, HC	1
Dabrowski, G; Graveleau, P; Grenet, D; Hurel, D; Legras, A; Loirat, P	1
Elderson, A; Verhoeven, WM; Westenberg, HG	1

Reviews

1 review(s) available for haloperidol decanoate and Neuroleptic Malignant Syndrome

Article	Year
[Life threatening neuroleptic malignant syndrome due to olanzapine]. Psychiatrische Praxis, 2003, Volume: 30, Issue:5 Topics: Antipsychotic Agents; Benzodiazepines; Critical Care; Electroconvulsive Therapy; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Psychotic Disorders; Recurrence	2003

Other Studies

6 other study(ies) available for haloperidol decanoate and Neuroleptic Malignant Syndrome

Article	Year
Neuroleptic malignant syndrome in a COVID-19 patient. Brain, behavior, and immunity, 2020, Volume: 88 Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coronavirus Infections; COVID-19; Dantrolene; Dopamine Agonists; Enzyme Inhibitors; Haloperidol; Humans; Hydroxychloroquine; Intensive Care Units; Leukocytosis; Lymphopenia; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Rhabdomyolysis; SARS-CoV-2; Schizophrenia	2020
[Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)]. Recenti progressi in medicina, 1996, Volume: 87, Issue:9 Topics: Acute Kidney Injury; Antipsychotic Agents; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Rhabdomyolysis	1996
Neuroleptic malignant syndrome. Journal of the South Carolina Medical Association (1975), 1992, Volume: 88, Issue:6 Topics: Adult; Antipsychotic Agents; Diagnosis, Differential; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome	1992
Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome? Neuropsychobiology, 1990, Volume: 23, Issue:1 Topics: Adult; Catatonia; Diagnosis, Differential; Haloperidol; Humans; Injections, Intramuscular; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders	1990
Protracted neuroleptic malignant syndrome complicating long-acting neuroleptic administration. The American journal of medicine, 1988, Volume: 85, Issue:6 Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Enterocolitis, Pseudomembranous; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome	1988
Neuroleptic malignant syndrome: successful treatment with bromocriptine. Biological psychiatry, 1985, Volume: 20, Issue:6 Topics: Adolescent; Basal Ganglia Diseases; Bromocriptine; Creatine Kinase; Haloperidol; Homovanillic Acid; Humans; Male; Neuroleptic Malignant Syndrome; Paranoid Disorders; Prolactin; Transaminases	1985